Cronos Group Inc.

CRON Healthcare Drug Manufacturers Specialty & Generic

Cronos Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.6 million, up 24.6% from fiscal 2024. In the quarter to June 2026, revenue grew 58.4%, EPS grew 190.0%, free cash flow grew 2,279.2% and total debt fell 4.71%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

3.22 0.02 +0.63%
Market cap
$1.2B
P/E
16.1×
Fwd P/E
32.2×
Dividend yield
—
F-score
5/9
Altman Z
12.67
Beneish M
−2.05
Dividend safety
20/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — 3 3 4 4 5 5 6 5
P/E ratio
769.70 769.70 0.00 1.93 0.00 0.00 0.00 0.00 19.52 0.00
Altman Z-Score
— — 30.26 5.47 7.95 14.86 9.20 12.10 9.71 12.67
P/S ratio
326.22 326.22 147.67 100.14 52.23 19.51 10.86 9.21 6.56 6.88
Altman Z″-Score (non-manufacturers)
3.08 7.15 3.43 10.66 13.39 27.48 22.17 31.90 26.91 28.18
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 135.66 0.00
P/Operating CF
(547.73) (547.73) 99.74 (44.47) (63.66) (40.40) (38.67) 47.80 99.97 85.22
Beneish M-Score
— 8.31 0.19 — — — (3.99) (2.26) (2.59) (2.05)
P/B ratio
15.42 15.42 12.05 1.36 1.43 1.09 0.83 0.73 0.69 0.88
Dividend Safety Score
— — — — — — — — — 20
EV/Sales
325.50 325.50 145.70 37.01 24.80 6.10 0.78 (0.64) (0.73) 1.21
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.73 1.28 0.00
EV/FCF
(27.54) (27.54) (18.38) (5.19) (6.43) (2.74) (0.72) 1.20 (15.12) (936.49)
Current Ratio
1.04 3.39 1.20 4.73 6.63 19.86 14.10 22.54 18.84 19.59
Net Debt/EBITDA
(0.31) 3.45 1.23 12.79 7.62 5.50 9.23 11.21 12.77 337.10
Debt/Equity
0.12 0.06 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00
ROE
(1.91%) 4.17% (20.11%) 122.95% (4.23%) (26.04%) (13.63%) (6.61%) 3.72% (0.84%)
ROA
(1.52%) 3.48% (16.55%) 102.60% (3.64%) (23.84%) (12.93%) (6.29%) 3.56% (0.80%)
ROIC
(3.89%) (1.60%) (10.70%) (30.32%) (26.26%) (36.55%) (25.38%) (22.44%) (18.89%) (3.34%)
Return on Tangible Assets
(8.24%) 3.32% (16.32%) 83.30% (5.41%) (36.03%) (17.71%) (7.77%) 4.03% (0.91%)
Average Days of Receivables
70.56 380.37 167.40 182.42 148.14 136.48 121.51 126.92 90.47 142.42
Earnings Yield
0.13% 0.13% (1.21%) 51.89% (2.88%) (11.22%) (18.00%) (9.00%) 5.12% (0.38%)
Free Cash Flow Yield
(3.62%) (3.62%) (5.37%) (7.12%) (7.39%) (11.42%) (9.97%) (5.80%) 0.74% (0.02%)
Free Cash Flow per Share
(0.08) (0.28) (0.56) (0.55) (0.51) (0.45) (0.25) (0.12) 0.01 0.00
Book value per Share
0.33 0.49 0.86 5.64 4.86 3.60 3.03 2.88 2.91 2.98
Free Cash Flow
(6.04) (37.22) (96.10) (169.23) (180.26) (165.88) (93.98) (46.26) 5.69 (0.19)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 1.12 0.00
Other line items

Show all line items

Columns are period end dates